Medhi B.
- Country
- France
- Department
- Medical oncology
Research Overview
- Evaluation of Bintrafusp Alfa and Doxorubicin Hydrochloride in Advanced Soft-Tissue Sarcoma: A Phase II Clinical Trial
- Randomized Phase II/III Study of Cabozantinib Maintenance Versus Best Supportive Care in Osteosarcoma Patients After First‑Line Chemotherapy (FOSTER‑CabOS)
- Evaluation of Spartalizumab and Low-Dose Pazopanib in Refractory or Relapsed Solid Tumors in Pediatric and Adult Cohorts
Data & Insights
Has run more than one trial at 9 of 74 partner sites.
Specializations
Solid Tumor Research
This investigator specializes in treating advanced and metastatic solid tumors, with particular emphasis on innovative therapeutic approaches for patients with refractory conditions.
- Advanced solid tumors
- Metastatic disease management
- Refractory tumor treatment
The research encompasses novel therapeutic combinations and targeted treatment strategies for solid tumor patients.
Sarcoma Specialization
Demonstrates significant expertise in treating various types of sarcomas, including specialized approaches for specific subtypes.
- Gastrointestinal Stromal Tumors (GIST)
- Ewing sarcoma
- Retroperitoneal sarcomas
- Soft tissue sarcomas
Focuses on both surgical and medical management of sarcomas, including advanced and metastatic cases.
Therapeutic Innovation
Actively involved in evaluating novel therapeutic agents and combination treatments for oncology patients.
- Immunotherapy applications
- Targeted therapy approaches
- Combination treatment strategies
Explores innovative treatment modalities including immunotherapy combinations and targeted molecular therapies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.